PacaƱa, Berlinda S.
HRN: 23-65-95 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/29/2023
MUPIROCIN 2%, 15G (TUBE)
09/29/2023
10/05/2023
TOPICAL
Apply On Skin
BID
Pressure Ulcer
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes